128 related articles for article (PubMed ID: 38479497)
21. Ambulatory Intravenous Inotropic Support and or Levosimendan in Pediatric and Congenital Heart Failure: Safety, Survival, Improvement, or Transplantation.
Apostolopoulou SC; Vagenakis GA; Tsoutsinos A; Kakava F; Rammos S
Pediatr Cardiol; 2018 Oct; 39(7):1315-1322. PubMed ID: 29777282
[TBL] [Abstract][Full Text] [Related]
22. Patients with cardiac amyloidosis have a greater neurohormonal activation than those with non-amyloidotic heart failure.
Vergaro G; Aimo A; Campora A; Castiglione V; Prontera C; Masotti S; Musetti V; Chianca M; Valleggi A; Spini V; Emdin M; Passino C
Amyloid; 2021 Dec; 28(4):252-258. PubMed ID: 34396857
[TBL] [Abstract][Full Text] [Related]
23. Comparative Effectiveness and Safety of Milrinone and Levosimendan as Initial Inotrope Therapy in Patients With Acute Heart Failure With Renal Dysfunction.
Cui X; Wang Z; Dong X; Cheng Z; Zhang L; Mu Y; Huang X; Li Y; Hong Y; Han Y
J Cardiovasc Pharmacol; 2022 Jun; 79(6):781-790. PubMed ID: 35507915
[TBL] [Abstract][Full Text] [Related]
24. Intermittent levosimendan infusions in advanced heart failure: a real world experience.
Ortis B; Villani A; Oldani M; Giglio A; Ciambellotti F; Facchini M; Parati G; Malfatto G
J Int Med Res; 2017 Feb; 45(1):361-371. PubMed ID: 28222634
[TBL] [Abstract][Full Text] [Related]
25. Economic analysis of intermittent intravenous outpatient treatment with levosimendan in advanced heart failure in Spain.
Manito Lorite N; Rubio-Rodríguez D; González Costello J; Díez López C; Enjuanes Grau C; Segovia-Cubero J; Delgado Jimenez JF; Campo Sien C; Rubio-Terrés C; Comín-Colet J; ;
Rev Esp Cardiol (Engl Ed); 2020 May; 73(5):361-367. PubMed ID: 31899185
[TBL] [Abstract][Full Text] [Related]
26. Levosimendan in acute heart failure following primary percutaneous coronary intervention-treated acute ST-elevation myocardial infarction. Results from the LEAF trial: a randomized, placebo-controlled study.
Husebye T; Eritsland J; Müller C; Sandvik L; Arnesen H; Seljeflot I; Mangschau A; Bjørnerheim R; Andersen GØ
Eur J Heart Fail; 2013 May; 15(5):565-72. PubMed ID: 23288914
[TBL] [Abstract][Full Text] [Related]
27. Safety and efficacy of levosimendan in patients with cardiac amyloidosis.
Aimo A; Rapezzi C; Arzilli C; Vergaro G; Emdin M
Eur J Intern Med; 2020 Oct; 80():114-116. PubMed ID: 32631802
[No Abstract] [Full Text] [Related]
28. Levosimendan Improves Clinical Outcomes of Refractory Heart Failure in Elderly Chinese Patients.
Zhang D; Yao Y; Qian J; Huang J
Med Sci Monit; 2015 Aug; 21():2439-45. PubMed ID: 26289557
[TBL] [Abstract][Full Text] [Related]
29. Short-term effect of levosimendan on free light chain kappa and lambda levels in patients with decompensated chronic heart failure.
Kurt IH; Yavuzer K; Batur MK
Heart Vessels; 2010 Sep; 25(5):392-9. PubMed ID: 20676961
[TBL] [Abstract][Full Text] [Related]
30. Effects of levosimendan on heart failure in normotensive patients: does loading dose matter?
Palmerini E; Söderberg S; Mondillo S; Favilli R; Lunghetti S
Acute Card Care; 2015 Mar; 17(1):14-9. PubMed ID: 25806830
[TBL] [Abstract][Full Text] [Related]
31. Intermittent inotropic therapy with levosimendan vs. milrinone in advanced heart failure patients.
Milwidsky A; Frydman S; Laufer-Perl M; Sadeh B; Sapir O; Granot Y; Hochstadt A; Korotetski L; Ketchker L; Topilsky Y; Banai S; Havakuk O
ESC Heart Fail; 2022 Apr; 9(2):1487-1491. PubMed ID: 35083882
[TBL] [Abstract][Full Text] [Related]
32. Prophylactic use of levosimendan in pediatric patients undergoing cardiac surgery: a prospective randomized controlled trial.
Wang A; Cui C; Fan Y; Zi J; Zhang J; Wang G; Wang F; Wang J; Tan Q
Crit Care; 2019 Dec; 23(1):428. PubMed ID: 31888711
[TBL] [Abstract][Full Text] [Related]
33. Levosimendan Reduces Mortality and Low Cardiac Output Syndrome in Cardiac Surgery.
Weber C; Esser M; Eghbalzadeh K; Sabashnikov A; Djordjevic I; Maier J; Merkle J; Choi YH; Madershahian N; Liakopoulos O; Deppe AC; Wahlers TCW
Thorac Cardiovasc Surg; 2020 Aug; 68(5):401-409. PubMed ID: 31770777
[TBL] [Abstract][Full Text] [Related]
34. Effects of levosimendan versus dobutamine on left atrial function in decompensated heart failure.
Duman D; Palit F; Simsek E; Bilgehan K; Sacide A
Can J Cardiol; 2009 Oct; 25(10):e353-6. PubMed ID: 19812809
[TBL] [Abstract][Full Text] [Related]
35. Rationale and design of a randomized, double-blind, placebo controlled multicenter trial to study efficacy, security, and long term effects of intermittent repeated levosimendan administration in patients with advanced heart failure: LAICA study.
García-González MJ; de Mora-Martín M; López-Fernández S; López-Díaz J; Martínez-Sellés M; Romero-García J; Cordero M; Lara-Padrón A; Marrero-Rodríguez F; del Mar García-Saiz M; Aldea-Perona A;
Cardiovasc Drugs Ther; 2013 Dec; 27(6):573-9. PubMed ID: 23887741
[TBL] [Abstract][Full Text] [Related]
36. Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial.
Gheorghiade M; Böhm M; Greene SJ; Fonarow GC; Lewis EF; Zannad F; Solomon SD; Baschiera F; Botha J; Hua TA; Gimpelewicz CR; Jaumont X; Lesogor A; Maggioni AP;
JAMA; 2013 Mar; 309(11):1125-35. PubMed ID: 23478743
[TBL] [Abstract][Full Text] [Related]
37. Intravenous levosimendan vs. dobutamine in acute decompensated heart failure patients on beta-blockers.
Bergh CH; Andersson B; Dahlström U; Forfang K; Kivikko M; Sarapohja T; Ullman B; Wikström G
Eur J Heart Fail; 2010 Apr; 12(4):404-10. PubMed ID: 20335355
[TBL] [Abstract][Full Text] [Related]
38. [Individualized use of levosimendan in cardiac surgery].
Woehrle T; Mehringer L; Juchem G; Dashkevich A; Weis M; Schünemann M; Kilger E
Anaesthesist; 2021 Mar; 70(3):204-212. PubMed ID: 33001236
[TBL] [Abstract][Full Text] [Related]
39. Effect of levosimendan in patients with acute decompensated heart failure : A meta-analysis.
Zhou S; Zhang L; Li J
Herz; 2019 Nov; 44(7):630-636. PubMed ID: 29637229
[TBL] [Abstract][Full Text] [Related]
40. The predictive value of QRS duration in response to levosimendan therapy in patients with decompensated heart failure.
Cetin M; Uçar O; Cicekçioğlu H; Güven Cetin Z; Sahin M; Vasfi Ulusoy F; Aydoğdu S
Acta Cardiol; 2012 Jun; 67(3):317-23. PubMed ID: 22870740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
